Orbera365 Intragastric Balloon System (Abbreviated as'Orbera365')

NCT07195708 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 144

Last updated 2026-04-27

No results posted yet for this study

Summary

To demonstrate the safety and efficacy of Orbera365 in obese populations to support the registration of Orbera365.

Conditions

Interventions

DEVICE

Treatment group

The treatment group was the group with the placement of Orbera 365 plus lifestyle management

Sponsors & Collaborators

  • Boston Scientific Corporation

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-05-30
Primary Completion
2028-04-30
Completion
2028-10-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07195708 on ClinicalTrials.gov